LAUSR

Circulating HMGB1 is increased in myelodysplastic syndrome but not in other bone marrow failure syndromes: proof-of-concept cross-sectional study

Sign Up to like & get
recommendations!
0 Published in 2022 at "Therapeutic Advances in Hematology"

DOI: 10.1177/20406207221125990

Abstract: Background: Myelodysplastic syndrome (MDS) is associated with persistent immune activation. High mobility group box-1 (HMGB1) is a ubiquitous, functionally diverse, non-histone intranuclear protein. During acute and chronic inflammatory states, HMGB1 is actively released by inflammatory… read more here.

Keywords: myelodysplastic syndrome; circulating hmgb1; iqr; hmgb1 ... See more keywords